Prichard R K
Vet Parasitol. 1985 Aug;18(2):103-10. doi: 10.1016/0304-4017(85)90060-3.
Antiparasitic drugs must be conducted to the parasite by the host and are therefore subject to physiological and biochemical processes in the host. Usually the efficacy of an antiparasitic drug will depend on a toxic concentration being presented to the parasite for sufficient time to lead to irreversible damage. Because many drugs are, in part, absorbed and transported to the site of the parasite by the circulatory system the area under the plasma concentration curve (AUC) may reflect availability of drug to the parasite and likely efficacy. A number of host physiological factors affect the AUC. Many anthelmintics are given orally as solids. Some absorption occurs in the rumen of ruminants, but many heterocyclic compounds such as the benzimidazoles require the low pH of the abomasum or gastric stomach to render them soluble. Certain disease states, including gastrointestinal parasitism, can cause the gastric pH to rise. This may in turn reduce solubility and absorption with resultant faster rate of excretion, particularly when accompanied by diarrhoea, and a reduced AUC. Once the anthelmintic has been absorbed, after oral or systemic administration, it is usually rapidly transported to the liver. The liver and adipose tissue may store the drug, releasing it over a period to produce a sustained effect as occurs with ivermectin, or it may rapidly metabolise it. A few anthelmintics, such as febantel, probably need to be metabolised in order to become active. However, more frequently the liver is involved in oxidation or reduction, followed by conjugation with sulfate, glucuronide or glutathione to render the drug more polar, to increase its molecular weight, inactivate it and facilitate its excretion. The rate of metabolism has been found to vary considerably between species and thus different dose rates and treatment are often required to achieve adequate antiparasite activity, with species such as deer, cattle and probably goats metabolising some anthelmintics faster than sheep. Some interesting possibilities for altering the absorption and metabolism of anthelmintics by the host may allow improved efficacy and reliability of antiparasite activity without necessarily increasing the dose rate of anthelmintic.
抗寄生虫药物必须由宿主传递至寄生虫,因此会受到宿主生理和生化过程的影响。通常,抗寄生虫药物的疗效取决于在足够长的时间内将有毒浓度的药物作用于寄生虫,从而导致不可逆的损伤。由于许多药物部分通过循环系统被吸收并转运至寄生虫所在部位,血浆浓度曲线下面积(AUC)可能反映药物对寄生虫的可利用性以及可能的疗效。许多宿主生理因素会影响AUC。许多驱虫药以固体形式口服给药。反刍动物的瘤胃会发生一些吸收,但许多杂环化合物,如苯并咪唑类,需要皱胃或胃的低pH值才能使其溶解。某些疾病状态,包括胃肠道寄生虫感染,可导致胃pH值升高。这可能进而降低溶解度和吸收,导致排泄速度加快,特别是伴有腹泻时,AUC降低。驱虫药经口服或全身给药后被吸收,通常会迅速转运至肝脏。肝脏和脂肪组织可能会储存药物,在一段时间内释放以产生持续作用,如伊维菌素的情况,或者可能会迅速将其代谢。一些驱虫药,如非班太尔,可能需要代谢才能变得活跃。然而,更常见的是肝脏参与氧化或还原,随后与硫酸盐、葡萄糖醛酸或谷胱甘肽结合,使药物更具极性,增加其分子量,使其失活并促进其排泄。已发现不同物种之间的代谢速率差异很大,因此通常需要不同的剂量率和治疗方法来实现足够的抗寄生虫活性,鹿、牛以及可能还有山羊等物种比绵羊更快地代谢某些驱虫药。通过宿主改变驱虫药吸收和代谢的一些有趣可能性,可能在不一定增加驱虫药剂量率的情况下提高抗寄生虫活性的疗效和可靠性。